JPRN-UMIN000022418已完成未知
Efficacy and safety of ledipasvir/sofosubuvir/ribavirin combination therapy for failures to daculatasvir/asunaprevir combination therapy. - LDV/SOF/RBV for failures to DCV/ASV.
Toranomon Hospital, Department of Hepatology.0 个研究点目标入组 20 人开始时间: 2016年5月23日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Patients with history of hypersensitivity to HCV NS5A inhibitors/ NS5B inhibitors/ ribavirin. 2) Patients with hepatocellular carcinoma. 3) Females who are pregnant or lactating. 4) Patients with renal dysfunction (eGFR <50 mL/min/1.73m2) and hemodialysis patients. 5) Unsuitable patients for this study who were evaluated by principal investigator.
研究者
相似试验
已完成
不适用
Effectiveness and safety of ledipasvir and sofosbuvir for patients infected with HCV genotype 1 in clinical practicesChronic hepatitis C genotype 1JPRN-UMIN000024007Kyushu University1,000
尚未招募
不适用
Efficacy and safety of ledipasvir and sofosbuvir in patients with chronic hepatitis CPatients with chronic hepatitis C virus infectionJPRN-UMIN000018561Osaka University Graduate School of Medicine, Department of Gastroenterology and Hepatology2,000
招募中
2 期
?Effect of sofosbuvir/ ledipasvir on COVID-19COVID-19 pneumonia.IRCT20100228003449N29Tehran University of Medical Sciences50
已完成
不适用
Efficacy and safety of Ledipasvir/Sofosbuvir in chronic hepatitis C of Genotype1b with chronic kidney disease(eGFR30-60ml/min/1.73m2)Chronic hepatitis CJPRN-UMIN000027851ippon Medical School Chiba Hokusoh Hospital700
招募中
不适用
Efficacy and safety of sofosbuvir and ribavirin in patients with chronic hepatitis CPatients with chronic hepatitis C virus infectionJPRN-UMIN000017703Osaka University Graduate School of Medicine, Department of Gastroenterology and Hepatology500